Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-r...
Gespeichert in:
Veröffentlicht in: | ImmunoHorizons 2021-02, Vol.5 (2), p.59-69 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 69 |
---|---|
container_issue | 2 |
container_start_page | 59 |
container_title | ImmunoHorizons |
container_volume | 5 |
creator | Luangrath, Mitchell A Schmidt, Megan E Hartwig, Stacey M Varga, Steven M |
description | Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection. |
doi_str_mv | 10.4049/immunohorizons.2000067 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486462073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</originalsourceid><addsrcrecordid>eNpVkVtr3DAQhUVpaUKavxD02Ben9uhmvxTC0ktgQ0u77auY2ONdFVvaSnJg--ujkG1I9DICne-MZg5jF019KWvZfXDzvPiwC9H9Cz5dQl2ONq_YKSgjKmMEvH52P2HnKf0pEmhkbYR8y06EUEKDUKdsu3EpLVT9oOQG8pnf0BzigW_4iqYpced53hFfL36b-PcYMvWZ4xadT5lf9UsmXtC9i5gfsJ8H3x-yw4n_dnFJ_NqPBXDBv2NvRpwSnR_rGfv1-dNm9bVaf_tyvbpaV72AzlSd0bIzAypNRgEYaYbbEVAqbLFpJaBG06A0qIA0mKYm05gWBj22RKobxRn7-Oi7X25nGvoyUsTJ7qObMR5sQGdfvni3s9twZ1voOiWhGLw_GsTwd6GU7exSX3aBnsKSLMhWSw1lkUWqH6V9DClFGp_aNLV9CMq-DMoegyrgxfNPPmH_YxH3A1CVYg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486462073</pqid></control><display><type>article</type><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</creator><creatorcontrib>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</creatorcontrib><description>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</description><identifier>ISSN: 2573-7732</identifier><identifier>EISSN: 2573-7732</identifier><identifier>DOI: 10.4049/immunohorizons.2000067</identifier><identifier>PMID: 33536235</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Epitopes, T-Lymphocyte - administration & dosage ; Epitopes, T-Lymphocyte - genetics ; Epitopes, T-Lymphocyte - immunology ; Female ; Fingolimod Hydrochloride - pharmacology ; Immunologic Memory ; Influenza Vaccines - administration & dosage ; Influenza Vaccines - genetics ; Influenza Vaccines - immunology ; Lung - immunology ; Lung - virology ; Memory T Cells - drug effects ; Memory T Cells - immunology ; Mice ; Mice, Inbred BALB C ; Respiratory Syncytial Virus Infections - immunology ; Respiratory Syncytial Virus Infections - prevention & control ; Respiratory Syncytial Viruses - immunology ; Vaccines, Synthetic - administration & dosage ; Vaccines, Synthetic - immunology</subject><ispartof>ImmunoHorizons, 2021-02, Vol.5 (2), p.59-69</ispartof><rights>Copyright © 2021 The Authors.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</citedby><cites>FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</cites><orcidid>0000-0001-7332-4290 ; 0000-0002-0967-7937</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,860,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33536235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luangrath, Mitchell A</creatorcontrib><creatorcontrib>Schmidt, Megan E</creatorcontrib><creatorcontrib>Hartwig, Stacey M</creatorcontrib><creatorcontrib>Varga, Steven M</creatorcontrib><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><title>ImmunoHorizons</title><addtitle>Immunohorizons</addtitle><description>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</description><subject>Animals</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Epitopes, T-Lymphocyte - administration & dosage</subject><subject>Epitopes, T-Lymphocyte - genetics</subject><subject>Epitopes, T-Lymphocyte - immunology</subject><subject>Female</subject><subject>Fingolimod Hydrochloride - pharmacology</subject><subject>Immunologic Memory</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza Vaccines - genetics</subject><subject>Influenza Vaccines - immunology</subject><subject>Lung - immunology</subject><subject>Lung - virology</subject><subject>Memory T Cells - drug effects</subject><subject>Memory T Cells - immunology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Respiratory Syncytial Virus Infections - immunology</subject><subject>Respiratory Syncytial Virus Infections - prevention & control</subject><subject>Respiratory Syncytial Viruses - immunology</subject><subject>Vaccines, Synthetic - administration & dosage</subject><subject>Vaccines, Synthetic - immunology</subject><issn>2573-7732</issn><issn>2573-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVtr3DAQhUVpaUKavxD02Ben9uhmvxTC0ktgQ0u77auY2ONdFVvaSnJg--ujkG1I9DICne-MZg5jF019KWvZfXDzvPiwC9H9Cz5dQl2ONq_YKSgjKmMEvH52P2HnKf0pEmhkbYR8y06EUEKDUKdsu3EpLVT9oOQG8pnf0BzigW_4iqYpced53hFfL36b-PcYMvWZ4xadT5lf9UsmXtC9i5gfsJ8H3x-yw4n_dnFJ_NqPBXDBv2NvRpwSnR_rGfv1-dNm9bVaf_tyvbpaV72AzlSd0bIzAypNRgEYaYbbEVAqbLFpJaBG06A0qIA0mKYm05gWBj22RKobxRn7-Oi7X25nGvoyUsTJ7qObMR5sQGdfvni3s9twZ1voOiWhGLw_GsTwd6GU7exSX3aBnsKSLMhWSw1lkUWqH6V9DClFGp_aNLV9CMq-DMoegyrgxfNPPmH_YxH3A1CVYg</recordid><startdate>20210203</startdate><enddate>20210203</enddate><creator>Luangrath, Mitchell A</creator><creator>Schmidt, Megan E</creator><creator>Hartwig, Stacey M</creator><creator>Varga, Steven M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7332-4290</orcidid><orcidid>https://orcid.org/0000-0002-0967-7937</orcidid></search><sort><creationdate>20210203</creationdate><title>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</title><author>Luangrath, Mitchell A ; Schmidt, Megan E ; Hartwig, Stacey M ; Varga, Steven M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3297-976497da56e7522747dbf2a45a8a1842a6a71a47a52e62710e71782d6f8ee59f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Epitopes, T-Lymphocyte - administration & dosage</topic><topic>Epitopes, T-Lymphocyte - genetics</topic><topic>Epitopes, T-Lymphocyte - immunology</topic><topic>Female</topic><topic>Fingolimod Hydrochloride - pharmacology</topic><topic>Immunologic Memory</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza Vaccines - genetics</topic><topic>Influenza Vaccines - immunology</topic><topic>Lung - immunology</topic><topic>Lung - virology</topic><topic>Memory T Cells - drug effects</topic><topic>Memory T Cells - immunology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Respiratory Syncytial Virus Infections - immunology</topic><topic>Respiratory Syncytial Virus Infections - prevention & control</topic><topic>Respiratory Syncytial Viruses - immunology</topic><topic>Vaccines, Synthetic - administration & dosage</topic><topic>Vaccines, Synthetic - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luangrath, Mitchell A</creatorcontrib><creatorcontrib>Schmidt, Megan E</creatorcontrib><creatorcontrib>Hartwig, Stacey M</creatorcontrib><creatorcontrib>Varga, Steven M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ImmunoHorizons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luangrath, Mitchell A</au><au>Schmidt, Megan E</au><au>Hartwig, Stacey M</au><au>Varga, Steven M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection</atitle><jtitle>ImmunoHorizons</jtitle><addtitle>Immunohorizons</addtitle><date>2021-02-03</date><risdate>2021</risdate><volume>5</volume><issue>2</issue><spage>59</spage><epage>69</epage><pages>59-69</pages><issn>2573-7732</issn><eissn>2573-7732</eissn><abstract>Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in young children. The T cell response plays a critical role in facilitating clearance of an acute RSV infection, and memory T cell responses are vital for protection against secondary RSV exposures. Tissue-resident memory (TRM) T cells have been identified as a subset of memory T cells that reside in nonlymphoid tissues and are critical for providing long-term immunity. There is currently limited information regarding the establishment and longevity of TRM T cell responses elicited following an acute RSV infection as well as their role in protection against repeated RSV infections. In this study, we examined the magnitude, phenotype, and protective capacity of TRM CD4 and CD8 T cells in the lungs of BALB/c mice following an acute RSV infection. TRM CD4 and CD8 T cells were established within the lungs and waned by 149 d following RSV infection. To determine the protective capacity of TRMs, FTY720 administration was used to prevent trafficking of peripheral memory T cells into the lungs prior to challenge of RSV-immune mice, with a recombinant influenza virus expressing either an RSV-derived CD4 or CD8 T cell epitope. We observed enhanced viral clearance in RSV-immune mice, suggesting that TRM CD8 T cells can contribute to protection against a secondary RSV infection. Given the protective capacity of TRMs, future RSV vaccine candidates should focus on the generation of these cell populations within the lung to induce effective immunity against RSV infection.</abstract><cop>United States</cop><pmid>33536235</pmid><doi>10.4049/immunohorizons.2000067</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7332-4290</orcidid><orcidid>https://orcid.org/0000-0002-0967-7937</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2573-7732 |
ispartof | ImmunoHorizons, 2021-02, Vol.5 (2), p.59-69 |
issn | 2573-7732 2573-7732 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299542 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals |
subjects | Animals CD4-Positive T-Lymphocytes - immunology CD8-Positive T-Lymphocytes - immunology Epitopes, T-Lymphocyte - administration & dosage Epitopes, T-Lymphocyte - genetics Epitopes, T-Lymphocyte - immunology Female Fingolimod Hydrochloride - pharmacology Immunologic Memory Influenza Vaccines - administration & dosage Influenza Vaccines - genetics Influenza Vaccines - immunology Lung - immunology Lung - virology Memory T Cells - drug effects Memory T Cells - immunology Mice Mice, Inbred BALB C Respiratory Syncytial Virus Infections - immunology Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Viruses - immunology Vaccines, Synthetic - administration & dosage Vaccines, Synthetic - immunology |
title | Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A46%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tissue-Resident%20Memory%20T%20Cells%20in%20the%20Lungs%20Protect%20against%20Acute%20Respiratory%20Syncytial%20Virus%20Infection&rft.jtitle=ImmunoHorizons&rft.au=Luangrath,%20Mitchell%20A&rft.date=2021-02-03&rft.volume=5&rft.issue=2&rft.spage=59&rft.epage=69&rft.pages=59-69&rft.issn=2573-7732&rft.eissn=2573-7732&rft_id=info:doi/10.4049/immunohorizons.2000067&rft_dat=%3Cproquest_pubme%3E2486462073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486462073&rft_id=info:pmid/33536235&rfr_iscdi=true |